Alicja K. R.
- Country
- Poland
- Department
- Ambulatoria Uniwersyteckie, Zespół Poradni Specjalistycznych NSSU, Poradnia Geriatryczna
Research Overview
Data & Insights
Has run more than one trial at 22 of 27 partner sites.
Specializations
Cardiovascular and Cerebrovascular Medicine
The investigator engages in therapeutic research targeting acute myocardial infarction, acute ischemic stroke, and hypertensive disorders, emphasizing novel strategies to reduce mortality and cardiovascular events.
- Acute Myocardial Infarction
- Acute Ischemic Stroke
- Hypertension Management
Focus includes interventions that improve cardiac function and cerebrovascular outcomes.
Neurodegenerative and Cognitive Disorders
Research activities concentrate on Alzheimer’s disease psychosis, mild cognitive impairment, and related neuropsychiatric symptoms, aiming to modify disease progression and improve cognition.
- Alzheimer’s Disease Psychosis
- Mild Cognitive Impairment
- Neuropsychiatric Symptom Management
Efforts are directed toward safe and effective therapeutic options for cognitive decline.
Autoimmune and Inflammatory Rheumatology
The investigator’s portfolio includes studies on axial spondyloarthritis, psoriatic arthritis, and systemic lupus erythematosus, focusing on disease remission and organ protection.
- Axial Spondyloarthritis
- Psoriatic Arthritis
- Systemic Lupus Erythematosus
Therapeutic goals involve controlling inflammation and preventing joint damage.
Endocrine and Rare Metabolic Disorders
Active involvement in trials for Cushing’s disease and rare glomerulonephritis reflects a commitment to addressing complex hormonal and renal pathologies.
- Cushing’s Disease
- Rare Glomerulonephritis
- Hormonal Regulation Therapies
Emphasis is placed on correcting endocrine imbalances and preserving renal function.
Hematologic Oncology
Work in this area includes investigation of treatment regimens for Hodgkin lymphoma, seeking to enhance response rates and long‑term survival.
- Hodgkin Lymphoma
- Advanced Lymphoma Therapies
- Metabolic Response Assessment
Therapeutic innovation focuses on optimizing chemotherapeutic combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.